Aspen Reports One-Year Symptom Improvements in Parkinson’s Patients Treated With Sasineprocel

March 19, 2026

Phase 3 of Neurocrine’s Ingrezza cerebral palsy trial unsuccessful

January 3, 2026

Ionis Plans to Advance Angelman drug Biogen with clinical success

July 25, 2024

Must Read

Why Every Pharma Company Needs a Unified Data Platform

August 29, 2026

AI-Powered Pharma Customer Engagement

August 29, 2026

Osivax Gets Flu Vaccine License to Go For Combo Shot Vision

August 29, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Another late-stage victory for Tezspire is achieved by AstraZeneca and Amgen, this time in esophagitis

Despite a mid-stage failure, Bausch + Lomb moves a medication for dry eye condition to Phase 3

Biokin’s Iza-Bren Meets Primary Endpoint in Phase 3 Panku-Lung01 Lung Cancer Trial

Definium Bags Major Phase 3 Victory With LSD Formula

Leo Pharma Pens Mega Deal to Buy Tanabe’s Skin Disease Drug

PTC Therapeutics Acquires ST-920 Fabry Disease Gene Therapy Program From Sangamo

Zealand Bags Huge Money By Selling Rights to Takeda’s Blood Cancer Drug

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Why Every Pharma Company Needs a Unified Data Platform

AI-Powered Pharma Customer Engagement

Top 10 Digital Risks Facing Biotech Companies

AI in GMP Compliance

Insights

Superbugs Could Be the Next Pandemic: We Need a Global, Comprehensive Plan to Address Them Now!

Editor Picks

Aspen Reports One-Year Symptom Improvements in Parkinson’s Patients Treated With Sasineprocel

Phase 3 of Neurocrine’s Ingrezza cerebral palsy trial unsuccessful

Ionis Plans to Advance Angelman drug Biogen with clinical success

Must Read

Why Every Pharma Company Needs a Unified Data Platform

AI-Powered Pharma Customer Engagement

Osivax Gets Flu Vaccine License to Go For Combo Shot Vision

Hot Topics

About Us

Follow Us